Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

Stroke · 2021 · PMC8547576 · PMID 34477459

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While those with a history of prior stroke or TIA appeared to benefit more, the interaction term was not significant ( P =0.08), and no other subgroups showed a trend toward a significant interaction.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.